-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
PharmaCyte Biotech, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2011 to Q2 2025.
- PharmaCyte Biotech, Inc. Nonoperating Income (Expense) for the quarter ending July 31, 2025 was -$7.51M, a 130% decline year-over-year.
- PharmaCyte Biotech, Inc. Nonoperating Income (Expense) for the twelve months ending July 31, 2025 was $2.83M, a 91.8% decline year-over-year.
- PharmaCyte Biotech, Inc. annual Nonoperating Income (Expense) for 2024 was $35M, a 296% increase from 2023.
- PharmaCyte Biotech, Inc. annual Nonoperating Income (Expense) for 2023 was $8.85M, a 314% increase from 2022.
- PharmaCyte Biotech, Inc. annual Nonoperating Income (Expense) for 2022 was $2.14M, a 1300% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)